Female sex and oral contraceptive use accelerate nicotine metabolism

被引:369
作者
Benowitz, Neal L.
Lessov-Schlaggar, Christina N.
Swan, Gary E.
Jacob, Peyton, III
机构
[1] Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Med Serv, San Francisco Gen Hosp Med Ctr, San Francisco, CA 94143 USA
[5] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA
关键词
D O I
10.1016/j.clpt.2006.01.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Several studies have reported that female smokers have a higher risk of lung cancer than male smokers. This could be related to sex differences in nicotine metabolism and related smoking behavior. This study tested the hypothesis that women metabolize nicotine more rapidly than men and that, among women, oral contraceptive users metabolize nicotine more rapidly than nonusers of oral contraceptives. Methods. Two hundred seventy-eight healthy volunteers who were twins and 16 who were siblings of twins, recruited from the Northern California Twin Registry, received an infusion of deuterium-labeled nicotine and cotinine with frequent blood sampling. The plasma clearances of nicotine and cotinine, the clearance of nicotine to cotinine (an index of cytochrome P450 [CYP] 2A6 activity), and the ratio of trans-3'-hydroxycotinine to cotinine (another indicator of CYP2A6 activity) were measured. Results: The clearances of nicotine and cotinine, the clearance of nicotine to cotinine, and the trans-3'-hydroxycotinine/cotinine ratio were significantly higher in women than in men (nicotine clearance, 15.6 +/- 4.3 mL (.) min(-1) (.) kg(-1) in men versus 18.8 +/- 6.6 mL (.) min(-1) (.) kg(-1) in women; P < .001); they were also higher among women taking oral contraceptives than in those who were not taking oral contraceptives (nicotine clearance, 22.5 +/- 6.6 mL (.) min(-1) (.) kg(-1) in women taking oral contraceptives versus 17.6 +/- 6.1 mL (.) min(-1 .) kg(-1) in those who were not; P < .05). Women who were menopausal or postmenopausal were not different from men. Among oral contraceptive users, nicotine metabolism was accelerated among those taking combined and estrogen-only contraceptives but not progesterone-only contraceptives. Conclusions: Sex hormones influence nicotine metabolism. Nicotine and cotinine metabolism is faster in women than in men and is faster in women taking oral contraceptives compared with those who are not. Accelerated nicotine metabolism appears to be a result of estrogen. Sex-related differences in nicotine clearance could affect smoking behaviors, as well as response to nicotine medications, and could be a marker for altered metabolism of nicotine-derived carcinogens.
引用
收藏
页码:480 / 488
页数:9
相关论文
共 39 条
  • [1] IMPAIRMENT OF DIAZEPAM METABOLISM BY LOW-DOSE ESTROGEN-CONTAINING ORAL-CONTRACEPTIVE STEROIDS
    ABERNETHY, DR
    GREENBLATT, DJ
    DIVOLL, M
    ARENDT, R
    OCHS, HR
    SHADER, RI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (13) : 791 - 792
  • [2] BALOGH A, 1995, EUR J CLIN PHARMACOL, V48, P161
  • [3] Gender differences in the pharmacology of nicotine addiction
    Benowitz, NL
    Hatsukami, D
    [J]. ADDICTION BIOLOGY, 1998, 3 (04) : 383 - 404
  • [4] GENDER DIFFERENCES IN SMOKING CESSATION AFTER 3 YEARS IN THE LUNG HEALTH STUDY
    BJORNSON, W
    RAND, C
    CONNETT, JE
    LINDGREN, P
    NIDES, M
    POPE, F
    BUIST, AS
    HOPPERYAN, C
    OHARA, P
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (02) : 223 - 230
  • [5] Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity
    Dempsey, D
    Tutka, P
    Jacob, P
    Allen, F
    Schoedel, K
    Tyndale, RF
    Benowitz, NL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) : 64 - 72
  • [6] Accelerated metabolism of nicotine and cotinine in pregnant smokers
    Dempsey, D
    Jacob, P
    Benowitz, NL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) : 594 - 598
  • [7] PROSPECTIVE-STUDY OF FACTORS PREDICTING OUTCOME OF TRANSDERMAL NICOTINE TREATMENT IN SMOKING CESSATION
    GOURLAY, SG
    FORBES, A
    MARRINER, T
    PETHICA, D
    MCNEIL, JJ
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6958) : 842 - 846
  • [8] Gender and the Effects of Different Doses of Nicotine Gum on Tobacco Withdrawal Symptoms
    Hatsukami, Dorothy
    Skoog, Kelli
    Allen, Sharon
    Bliss, Robin
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1995, 3 (02) : 163 - 173
  • [9] HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
  • [10] Women's susceptibility to tobacco carcinogens
    Henschke, CI
    Miettinen, OS
    [J]. LUNG CANCER, 2004, 43 (01) : 1 - 5